Transarterial chemoembolization as initial treatment for unresectable hepatocellular carcinoma in southern China

被引:0
|
作者
Ming Shi
机构
关键词
Hepatocellular carcinoma; Transarterial chemoembolization; Palliative treatment; Prognosis;
D O I
暂无
中图分类号
R735.7 [肝肿瘤];
学科分类号
100214 ;
摘要
AIM:To identify prognostic factors from pretreatment variables of the initial transarterial chemoembolization(TACE)procedure in unresectable hepatocellular carcinoma(HCC). METHODS:One thousand and five hundred and sixtynine patients with unresectable HCC underwent TACE as initial treatment were retrospectively studied.Pretreatment variables of the initial TACE procedure with a P value less than 0.05 by univariate analysis were subjected to Cox proportional hazards model. RESULTS:The median overall survival time and 1-, 5-,10-year survival rates were 10.37 mo,47%,10%, and 7%,respectively.A Cox proportional hazard model showed that 8 pretreatment factors of regional lymphnodes metastasis,Child-Pugh class,macrovascular invasion,greatest dimension,α-fetoprotein(AFP), Hepatitis virus B,tumor capsule,and nodules were independent prognostic factors.Patients with multimodality therapy have better survival than those with TACE treatment only. CONCLUSION:Tumor status,hepatic function reserve,AFP,and hepatitis virus B status were independent prognostic factors for unresectable HCC.Distant metastasis might not be a contraindication to TACE. Multimodality therapy might improve survival.
引用
收藏
页码:264 / 269
页数:6
相关论文
共 50 条
  • [31] Timely repeated transarterial chemoembolization in patients with unresectable hepatocellular carcinoma who showed initial antitumoral effect
    Park, CH
    Lee, WS
    Joo, YE
    Choi, SK
    Rew, JS
    Kim, JK
    Kim, SJ
    JOURNAL OF HEPATOLOGY, 2003, 38 : 99 - 99
  • [32] Factors Predicting Survival after Transarterial Chemoembolization of Unresectable Hepatocellular Carcinoma
    Hanif, Farina M.
    Tasneem, Abbas Ali
    Luck, Nasir Hassan
    Abbas, Zaigham
    Hassan, Syed Mujahid
    Mubarak, Muhammed
    MIDDLE EAST JOURNAL OF CANCER, 2014, 5 (04) : 197 - 205
  • [33] Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma
    Lo, CM
    Ngan, H
    Tso, WK
    Liu, CL
    Lam, CM
    Poon, RTP
    Fan, ST
    Wong, J
    HEPATOLOGY, 2002, 35 (05) : 1164 - 1171
  • [34] Pilot Study of Transarterial Chemoembolization With Pirarubicin and Amiodarone for Unresectable Hepatocellular Carcinoma
    Guiu, Boris
    Colin, Cedric
    Cercueil, Jean-Pierre
    Loffroy, Romaric
    Guiu, Severine
    Ferrant, Emmanuelle
    Jouve, Jean-Louis
    Bonnetain, Franck
    Boulin, Mathieu
    Ghiringhelli, Francois
    Minello, Anne
    Hillon, Patrick
    Bedenne, Laurent
    Krause, Denis
    Chauffert, Bruno
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2009, 32 (03): : 238 - 244
  • [35] Lenvatinib in combination with transarterial chemoembolization for treatment of unresectable hepatocellular carcinoma (uHCC): a retrospective controlled study
    Fu, Zhigang
    Li, Xiaowei
    Zhong, Jiaming
    Chen, Xiaoxia
    Cao, Kunkun
    Ding, Ning
    Liu, Li
    Zhang, Xiaoli
    Zhai, Jian
    Qu, Zengqiang
    HEPATOLOGY INTERNATIONAL, 2021, 15 (03) : 663 - 675
  • [36] Safety and Efficacy of Transarterial Chemoembolization and Immune Checkpoint Inhibition with Camrelizumab for Treatment of Unresectable Hepatocellular Carcinoma
    Zhang, Jin-Xing
    Chen, Pei
    Liu, Sheng
    Zu, Qing-Quan
    Shi, Hai-Bin
    Zhou, Chun-Gao
    JOURNAL OF HEPATOCELLULAR CARCINOMA, 2022, 9 : 265 - 272
  • [37] The Use of Transarterial Chemoembolization in the Treatment of Unresectable Hepatocellular Carcinoma: A Response to the Cochrane Collaboration Review of 2011
    Ray, Charles E., Jr.
    Haskal, Ziv J.
    Geschwind, Jean-Francois H.
    Funaki, Brian S.
    JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY, 2011, 22 (12) : 1693 - 1696
  • [38] Lenvatinib in combination with transarterial chemoembolization for treatment of unresectable hepatocellular carcinoma (uHCC): a retrospective controlled study
    Zhigang Fu
    Xiaowei Li
    Jiaming Zhong
    Xiaoxia Chen
    Kunkun Cao
    Ning Ding
    Li Liu
    Xiaoli Zhang
    Jian Zhai
    Zengqiang Qu
    Hepatology International, 2021, 15 : 663 - 675
  • [39] Improved Time to Progression for Transarterial Chemoembolization Compared With Transarterial Embolization for Patients With Unresectable Hepatocellular Carcinoma
    Morse, Michael A.
    Hanks, Brent A.
    Suhocki, Paul
    Doan, Phuong L.
    Liu, Emily A.
    Frost, Patricia
    Bernard, Stephen A.
    Tsai, Andrea
    Moore, Dominic T.
    O'Neil, Bert H.
    CLINICAL COLORECTAL CANCER, 2012, 11 (03) : 185 - 190
  • [40] Transarterial chemoembolization of hepatocellular carcinoma
    Huppert, Peter
    RADIOLOGE, 2022, 62 (03): : 225 - 233